GILD
49
-3
LNC
58
-7
VFC
33
-3
OKE
43
-5
MCHP
68
-4
NEM
46
-9
PPG
50
-3
LH
50
-2
MET
44
-3
GPC
53
-5
SHW
55
-3
CMA
50
-9
XYL
54
-6
EIX
34
-3
BF.B
44
-2
ES
47
-2
AZO
50
-6
EQR
33
-3
GM
61
-4
ICE
49
-6
GILD
49
-3
LNC
58
-7
VFC
33
-3
OKE
43
-5
MCHP
68
-4
NEM
46
-9
PPG
50
-3
LH
50
-2
MET
44
-3
GPC
53
-5
SHW
55
-3
CMA
50
-9
XYL
54
-6
EIX
34
-3
BF.B
44
-2
ES
47
-2
AZO
50
-6
EQR
33
-3
GM
61
-4
ICE
49
-6
Financhill
Back

iShares LifePath Target Date 2040 ETF Vs. Nektar Therapeutics Industry Stock Comparison

Buy
55

ITDD
iShares LifePath Target Date 2040 ETF

Last Price:
$32.96
Seasonality Move:
7.11%
Buy
51

NKTR
Nektar Therapeutics

Last Price:
$23.88
Seasonality Move:
2.04%
Buy
55
iShares LifePath Target Date 2040 ETF (ITDD) is a Buy

Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?

  • The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $32.95. The Score for ITDD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • ITDD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $23.80. The Score for NKTR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ITDD Stock Price Chart

What is iShares LifePath Target Date 2040 ETF's stock price today?

  • The iShares LifePath Target Date 2040 ETF share price today is $32.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITDD is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $23.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.

ITDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.7 Buy
Relative Strength Index (14 RSI): 59.33 Buy
Chaikin Money Flow: -12024 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.27 - 33.07) Buy
Bollinger Bands (100): (30.05 - 32.41) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.37 Buy
Relative Strength Index (14 RSI): 61.65 Buy
Chaikin Money Flow: -131709 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.78 - 26.76) Buy
Bollinger Bands (100): (7.5 - 18.34) Buy

ITDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.08 Sell
20-day SMA: 32.77 Buy
50-day SMA: 32.12 Buy
200-day SMA: 31.25 Buy
8-day EMA: 25.74 Buy
20-day EMA: 14.93 Buy
50-day EMA: 7.06 Buy
200-day EMA: 1.93 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.08 Sell
20-day SMA: 21.11 Buy
50-day SMA: 14.55 Buy
200-day SMA: 14.61 Buy
8-day EMA: 18.83 Buy
20-day EMA: 10.89 Buy
50-day EMA: 5.14 Buy
200-day EMA: 1.4 Buy

iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.

iShares LifePath Target Date 2040 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):